FOCUSau

In-person psychoeducational interventions (approaches that focus on improving health outcomes through tailored information) have shown improvements in the QoL of patients with advanced cancer and carer wellbeing. FOCUS is an evidence-based, dyadic, psychoeducational digital-health intervention (developed in the USA) which has been shown to improve the wellbeing and QoL of patients with advanced cancer and their primary family carer. Our research seeks to enhance palliative and end-of-life (EoL) care in Australia by; (1) finalising the adaptation of the iFOCUS program to FOCUSau (for use in the trial); (2) examining the clinical and health economic benefits of FOCUSau; and (3) assessing the acceptability, feasibility, and scalability of FOCUSau in order to inform the sustainable implementation of the intervention into the Australian health care system. We are conducting a pragmatic phase III hybrid effectiveness-implementation trial, with an integrated research design that includes digital health evaluation. 

Category
Trial Status
Active, not recruiting
Trial Phase
Other
ERM Project ID
84479
Trial contact details
Contact Person
Karyn Foster
What you need to know

Who can take part?

Adult patients with advanced cancer and have a primary support person/carer.

 

What is involved for me?

- interacting with the researcher via videoconferencing
- accessing and interacting with an online support program 
- complete a questionnaire and be allocated to the study group
- 4 x online sessions - 3 weeks apart (approx. 35mins)
- optional interview with researcher post completion
- two further questionnaires (approx. 35mins each) at 12 weeks and 24 weeks post commencement

All research clinical trials news

2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.

29

Feb

Highlighting Mater Research’s year of achievements: 2023 Annual Report

When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.

27

Oct

Clinical trials give Queensland breast cancer patients hope

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.

23

May

Mater launches trial of Australian-first flu vaccine

Displaying results 1-3 (of 18)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|